Bacille Calmette Guerin immunization of health care workers exposed to multidrug-resistant tuberculosis: A decision analysis

Tubercle and Lung Disease

Volumn 77, Issue 4, 1996, Pages 315-321

  Stevens, J P ^a   Daniel, T M ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CIPROFLOXACIN; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ARTICLE; BCG VACCINATION; CHEMOPROPHYLAXIS; COMPUTER PROGRAM; HEALTH CARE PERSONNEL; MEDICAL DECISION MAKING; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; TUBERCULOSIS; TUBERCULOSIS CONTROL; COMPARATIVE STUDY; DECISION SUPPORT SYSTEM; HUMAN; PROBABILITY; VACCINATION;

ANTITUBERCULAR AGENTS; BCG VACCINE; CIPROFLOXACIN; DECISION SUPPORT TECHNIQUES; HEALTH PERSONNEL; HUMANS; PROBABILITY; PYRAZINAMIDE; SOFTWARE; TUBERCULOSIS, MULTIDRUG-RESISTANT; VACCINATION;

EID: 0029665429     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(96)90095-7     Document Type: Article

References (32)

1. Cantwell M F, Snider D E Jr, Cauthen G M, Onorato I M. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA 1994; 272: 535-539.
2. Raviglione M C, Snider D E Jr, Kochi A. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
3. Snider D E, Roper W L. The new tuberculosis. New Engl J Med 1992; 325: 703-705.
4. Frieden T R, Sterling T, Pablos-Mendez A, Kilburn J O, Cauthen G M, Dooley S W. The emergence of drug-resistant tuberculosis in New York City. New Engl J Med 1993; 328: 521-526.
5. Small P M, Shafer R W, Hopewell P C et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. New Engl J Med 1993; 328: 1137-1144.
6. Neville K, Bromberg A, Bromberg R, Bonk S, Hanna B A, Rom W N. The third epidemic - multidrug-resistant tuberculosis. Chest 1994; 105: 45-48.
7. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-749.
8. Dunlap N E, Kimerling M E. Drug-resistant tuberculosis in adults: implications for the health care worker. Infect Agents Dis 1994; 3: 245-255.
9. Brewer T F, Colditz G A. Bacille Calmette-Guérin vaccination for the prevention of tuberculosis in health care workers. Clin Infect Dis 1995; 20: 136-142.
10. Greenberg P D, Lax K G, Schecter C B. Tuberculosis in house staff. A decision analysis comparing the tuberculin screening strategy with BCG vaccination. Am Rev Respir Dis 1991; 143: 490-495.
11. Villarino M E, Dooley S W Jr, Geiter L J, Castro K G, Snider D E Jr. Management of persons exposed to multidrug-resistant tuberculosis. MMWR 1992; 41 (RR-11): 61-71.
12. Stevens J P, Daniel T M. Chemoprophylaxis of multidrug-resistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide: A decision analysis. Chest 1995; 108: 712-717.
13. Pauker S G, Kassirer J P. Decision analysis. New Engl J Med 1987; 316: 250-258.
14. Ferebee S H. Controlled chemoprophylaxis trials in tuberculosis. A general review. Biol Tuberc 1970; 17: 28-106.
15. Comstock G W, Ferebee S H, Hammes L M. A controlled trial of community-wide isoniazid prophylaxis in Alaska. Am Rev Respir Dis 1967; 95: 935-943.
16. Comstock G W, Baum C, Snider D E Jr. Isoniazid prophylaxis among Alaskan Eskimos: a final report of the Bethel isoniazid studies. Am Rev Respir Dis 1979; 119: 827-830.
17. Lees H D. Tuberculosis in medical students and nurses. JAMA 1951; 147: 1754-1757.
18. Atuk N O, Hunt E H. Serial tuberculin testing and isoniazid therapy in general hospital employees. JAMA 1971; 218: 1795-1798.
19. Ruben F L, Norden C W, Schuster N. Analysis of a community hospital employee tuberculosis screening program 31 months after its inception. Am Rev Respir Dis 1977; 115: 23-28.
20. Chan J C, Tabak J I. Risk of tuberculous infection among house staff in an urban teaching hospital. South Med J 1985; 78: 1061-1064.
21. Colditz G A, Brewer T F, Berkey C S et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
22. Department of Health and Human Services, Centers for Disease Control and Prevention. Tuberculosis Notes, Fall, 1993.
23. Barrett-Connor E. The epidemiology of tuberculosis in physicians. JAMA 1979; 241: 33-38.
24. Snider D E Jr. Decision analysis for isoniazid preventive therapy: Take it or leave it? Am Rev Respir Dis 1988; 137: 2-4.
25. Alling D W, Bosworth E B. The after-history of pulmonary tuberculosis. VI. The first fifteen years following diagnosis. Am Rev Respir Dis 1960; 81: 839-849.
26. Comstock G W, Edwards P Q. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. Am Rev Respir Dis 1975; 111: 573-577.
27. Roussouw J E, Saunders S J. Hepatic complications of antituberculous therapy. Quart J Med 1975; 44: 1-16.
28. Mandell G L, Sande M A. Drugs used in the chemotherapy of tuberculosis and leprosy. In: Goodman A G, Rall T W, Nilles A S, Taylor P, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 8th ed. Pergamon Press, 1990: 1146-1149.
29. Rose D N, Scheeter C G, Silver A L. The age threshold for isoniazid chemoprophylaxis. A decision analysis for low-risk tuberculin reactors. JAMA 1986; 256: 2709-2713.
30. Fox W. Whither short-course chemotherapy? Br J Dis Chest 1981; 75: 331-357.
31. Goble M, Iseman M D, Madsen R N-C, Waite D, Ackerson L, Horsburgh C R Jr. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993; 328: 527-532.
32. Driver C R, Frieden T R, Bloch A B, Onorato I M. Drug resistance among tuberculosis patients, New York City, 1991 and 1992. Public Health Rep 1994; 109: 632-636.